Home > Boards > US Listed > Biotechs > Chembio Diagnostics (CEMI)

Research and Development

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
XenaLives Member Profile
Member Level 
Followed By 348
Posts 46,379
Boards Moderated 26
Alias Born 09/20/01
160x600 placeholder
Chembio Diagnostics Announces CE Mark for DPP SARS-CoV-2 Antigen and IgM/IgG Test Systems GlobeNewswire Inc. - 1/14/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/18/2020 9:24:22 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/18/2020 9:22:35 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/17/2020 5:15:40 PM
Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors GlobeNewswire Inc. - 12/17/2020 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/4/2020 6:05:19 AM
Chembio Diagnostics Awarded $12.7 Million by BARDA for Development of Rapid DPP Respiratory Antigen Panel and 510(k) Submissi... GlobeNewswire Inc. - 12/2/2020 1:22:29 PM
Chembio Diagnostics Receives ANVISA Approval for DPP SARS-CoV-2 Antigen Test System in Brazil GlobeNewswire Inc. - 11/13/2020 4:40:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2020 5:11:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2020 4:17:04 PM
Chembio Diagnostics Reports Third Quarter 2020 Financial Results GlobeNewswire Inc. - 11/5/2020 4:05:00 PM
Chembio Diagnostics to Report Third Quarter 2020 Financial Results on November 5, 2020 GlobeNewswire Inc. - 10/23/2020 8:00:10 AM
Chembio Diagnostics Submits EUA Application for DPP SARS-CoV-2 Antigen Test System GlobeNewswire Inc. - 10/15/2020 5:55:10 PM
Chembio Diagnostics Receives FDA Approval for DPP HIV-Syphilis System GlobeNewswire Inc. - 10/2/2020 7:26:09 AM
Chembio Submits EUA Application for New DPP SARS-CoV-2 IgM/IgG Test System GlobeNewswire Inc. - 9/8/2020 6:01:08 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2020 7:43:29 AM
Chembio Diagnostics Reports Second Quarter 2020 Financial Results GlobeNewswire Inc. - 8/6/2020 4:05:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/4/2020 7:19:40 AM
Chembio Diagnostics to Report Second Quarter 2020 Financial Results on August 6, 2020 GlobeNewswire Inc. - 7/23/2020 4:10:10 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/8/2020 10:00:37 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/8/2020 9:43:40 AM
Chembio Diagnostics Announces Preliminary Estimates of Second Quarter 2020 Revenues GlobeNewswire Inc. - 7/6/2020 4:23:03 PM
Chembio Announces Plans to Seek EUA Approval from FDA for Revised DPP COVID-19 IgM/IgG System and New DPP COVID-19 Antigen Sy... GlobeNewswire Inc. - 7/6/2020 4:11:10 PM
Chembio Diagnostics Awarded BARDA Contract for Development of DPP COVID-19 Point-of-Care Antigen System GlobeNewswire Inc. - 7/6/2020 4:10:10 PM
Chembio to Report COVID-19 Product Development Plans and Preliminary Estimated Second Quarter 2020 Revenue Results GlobeNewswire Inc. - 7/1/2020 5:00:10 PM
XenaLives Member Level  Thursday, 10/08/20 11:17:34 AM
Re: None
Post # of 456 
Quote:

Research and Development
Chembio is committed to developing highly accurate, affordable, efficient point-of-care rapid test products to help prevent the spread of infectious diseases worldwide. Chembio has been a key OEM provider to global brands in the diagnostic industry for many years, and our experienced management and R&D teams are constantly looking for ways to provide innovative solutions for healthcare providers everywhere.

Currently, we partner with not only commercial organizations but also foundations, NGOs, and healthcare organizations to research and develop faster, more accurate rapid diagnostic devices. Our work focuses on the areas of HIV, STDs and TB, and other Infectious Diseases all which have established Chembio as one of the cutting-edge companies in the medical diagnostic assay industry.





http://chembio.com/innovation/research-and-development/


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences